United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-259_547d7842-83a5-d943-e063-6294a90ae17d
- Product NDC
- 76420-259
- Form
- CAPSULE
- Composition / generic term
- Gabapentin
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160218
- Source listing expiry
- 20271231
Source-listed ingredients
- GABAPENTIN — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE, PLASTIC (76420-259-01) · 76420-259-01
- 500 CAPSULE in 1 BOTTLE, PLASTIC (76420-259-05) · 76420-259-05
- 120 CAPSULE in 1 BOTTLE, PLASTIC (76420-259-12) · 76420-259-12
- 30 CAPSULE in 1 BOTTLE, PLASTIC (76420-259-30) · 76420-259-30
- 60 CAPSULE in 1 BOTTLE, PLASTIC (76420-259-60) · 76420-259-60
- 90 CAPSULE in 1 BOTTLE, PLASTIC (76420-259-90) · 76420-259-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →